In an era of increasingly individualized healthcare, Elizabeth Philp has emerged as a significant figure of innovation, notably in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a push to make bespoke medications more accessible, disrupting the standard one-size-fit